ALPINE IMMUNE SCIENCES, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
ALPINE IMMUNE SCIENCES, INC. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$8.44 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-05-02
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$8.44M.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was -$5.18M.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-09-30 was -$7.52M.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-06-30 was -$6.55M.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$26.26M.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$19.21M.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$14.45M.
- ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$14.29M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$8.44M 10-Q · filed 2017-05-02 | -$13.61M derived: sum of 2 quarters · filed 2017-05-02 | -$21.14M derived: sum of 3 quarters · filed 2017-05-02 | -$27.68M derived: sum of 4 quarters · filed 2017-05-02 |
| 2016-12-31 | -$5.18M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | -$12.70M derived: sum of 2 quarters · filed 2017-02-13 | -$19.25M derived: sum of 3 quarters · filed 2017-02-13 | -$26.26M 10-K · filed 2017-02-13 |
| 2016-09-30 | -$7.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$14.07M derived: sum of 2 quarters · filed 2016-11-07 | -$21.08M 10-Q · filed 2016-11-07 | -$26.48M derived: sum of 4 quarters · filed 2017-05-02 |
| 2016-06-30 | -$6.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | -$13.56M 10-Q · filed 2016-08-02 | -$18.96M derived: sum of 3 quarters · filed 2017-05-02 | -$24.68M derived: sum of 4 quarters · filed 2017-05-02 |
| 2016-03-31 | -$7.01M 10-Q · filed 2017-05-02 | -$12.41M derived: sum of 2 quarters · filed 2017-05-02 | -$18.14M derived: sum of 3 quarters · filed 2017-05-02 | -$21.32M derived: sum of 4 quarters · filed 2017-05-02 |
| 2015-12-31 | -$5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | -$11.13M derived: sum of 2 quarters · filed 2017-02-13 | -$14.31M derived: sum of 3 quarters · filed 2017-02-13 | -$19.21M 10-K · filed 2017-02-13 |
| 2015-09-30 | -$5.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$8.91M derived: sum of 2 quarters · filed 2016-11-07 | -$13.81M 10-Q · filed 2016-11-07 | -$16.98M derived: sum of 4 quarters · filed 2017-02-13 |
| 2015-06-30 | -$3.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | -$8.08M 10-Q · filed 2016-08-02 | -$11.25M derived: sum of 3 quarters · filed 2017-02-13 | -$14.37M derived: sum of 4 quarters · filed 2017-02-13 |
| 2015-03-31 | -$4.89M 10-Q · filed 2016-05-03 | -$8.06M derived: sum of 2 quarters · filed 2017-02-13 | -$11.19M derived: sum of 3 quarters · filed 2017-02-13 | |
| 2014-12-31 | -$3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | -$6.29M derived: sum of 2 quarters · filed 2017-02-13 | -$14.45M 10-K · filed 2017-02-13 | |
| 2014-09-30 | -$3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | -$11.28M 10-Q · filed 2015-11-03 | ||
| 2014-06-30 | -$8.16M 10-Q · filed 2015-08-04 | |||
| 2013-12-31 | -$14.29M 10-K · filed 2016-03-08 |